E-LIB Suche - Ergebnisse für: Nozzolillo, Agostino

1

Fast but not furious: Rapid ocrelizumab infusion as a strat..:

Zanetta, Chiara ; Faustino, Patricia ; Guerrieri, Simone...
Journal of the Neurological Sciences. 457 (2024) - p. 122897 , 2024

Link: https://doi.org/10.1016/..

2

Modifiable risk factors of COVID-19 in patients with multip..:

Montini, Federico ; Nozzolillo, Agostino ; Rancoita, Paola M. V....
Journal of Neurology. 270 (2023) 4 - p. 1835-1842 , 2023

Link: https://doi.org/10.1007/..

3

Ocrelizumab extended‐interval dosing in multiple sclerosis ..:

Guerrieri, Simone ; Bucca, Chiara ; Nozzolillo, Agostino...
European Journal of Neurology. 30 (2023) 9 - p. 2859-2864 , 2023

Link: https://doi.org/10.1111/..

4

COVID-19 outbreak in Italy: an opportunity to evaluate exte..:

Bisecco, Alvino ; Matrone, Federica ; Capobianco, Marco...
Journal of Neurology. , 2023

Link: https://doi.org/10.1007/..

5

Sexual Dysfunction in People with Multiple Sclerosis: The R..:

Scandurra, Cristiano ; Rosa, Laura ; Carotenuto, Antonio...
Journal of Clinical Medicine. 12 (2023) 6 - p. 2215 , 2023

Link: https://doi.org/10.3390/..

6

Modifiable Risk Factors of COVID-19 in Patients with Multip..:

Montini, Federico ; Nozzolillo, Agostino ; Rancoita, Paola M.V....
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

7

Safety of Natalizumab infusion in multiple sclerosis patien..:

Landi, Doriana ; Cola, Gaia ; Mantero, Vittorio...
Multiple Sclerosis and Related Disorders. 57 (2022) - p. 103345 , 2022

Link: https://doi.org/10.1016/..

8

The impact of COVID-19 on people with multiple sclerosis: A..:

Schwartz, Carolyn E. ; Rapkin, Bruce D. ; Bonavita, Simona...
Multiple Sclerosis and Related Disorders. 63 (2022) - p. 103888 , 2022

Link: https://doi.org/10.1016/..

9

Atrioventricular block after fingolimod resumption: a conse..:

Orrico, Mario ; Nozzolillo, Agostino ; Gelibter, Stefano...
Journal of Neurology. 268 (2021) 11 - p. 3975-3979 , 2021

Link: https://doi.org/10.1007/..

10

Use of Alemtuzumab in a real-world clinical setting: The ex..:

Zanetta, Chiara ; Nozzolillo, Agostino ; Guerrieri, Simone...
Journal of the Neurological Sciences. 429 (2021) - p. 118158 , 2021

Link: https://doi.org/10.1016/..

11

Prognostic factors related to the risk of COVID-19 infectio..:

Montini, Federico ; Nozzolillo, Agostino ; Moiola, Lucia...
Journal of the Neurological Sciences. 429 (2021) - p. 118236 , 2021

Link: https://doi.org/10.1016/..

12

Ocrelizumab depletes T-lymphocytes more than rituximab in m..:

Capasso, Nicola ; Nozzolillo, Agostino ; Scalia, Giulia...
Multiple Sclerosis and Related Disorders. 49 (2021) - p. 102802 , 2021

Link: https://doi.org/10.1016/..

13

Italian multicenter observational study on real-life experi..:

Moiola, Lucia ; Zanetta, Chiara ; Di Cristinzi, Maria...
Journal of the Neurological Sciences. 429 (2021) - p. 118109 , 2021

Link: https://doi.org/10.1016/..

14

Physical Exercise Moderates the Effects of Disability on De..:

Carotenuto, Antonio ; Scandurra, Cristiano ; Costabile, Teresa...
Journal of Clinical Medicine. 10 (2021) 6 - p. 1234 , 2021

Link: https://doi.org/10.3390/..

15

Perampanel Confirms to Be Effective and Well-Tolerated as a..:

Coppola, Antonietta ; Zarabla, Alessia ; Maialetti, Andrea...
Frontiers in Neurology. 11 (2020) - p. , 2020

Link: https://doi.org/10.3389/..